MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

Earlier studies indicated that COVID infection might cause MS symptoms to worsen, particularly if the symptoms coincide with those associated with long COVID. For this new study, researchers tracked ...

The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...